Your search for smoking cessation returned 23 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Mpr-drug-news remove
Da Hee Han, PharmD remove
Older than 2 years remove

Your search for smoking cessation returned 23 results

Sort Results:

Relevant Recent

FDA Committees Weigh In on Boxed Warning for Chantix

At a joint meeting of the Food and Drug Administration (FDA)'s Psychopharmacologic Drugs Advisory Committee and Drug Safety Risk Management Advisory Committee, a majority vote recommended the removal of the boxed warning regarding serious neuropsychiatric adverse events from the Chantix (varenicline; Pfizer) labeling.

Drug Combo May Benefit Weight-Concerned Smokers Who Want to Quit

In a first-ever prospective study evaluating lorcaserin in reducing post-cessation weight gain in overweight and obese smokers, researchers found that lorcaserin combined with varenicline minimized weight gain and increases in waist circumference.

Quit Rates for 3 Smoking Cessation Therapies Compared

Researchers found no significant differences in rates of smoking abstinence at 26 or 52 weeks following a 12-week treatment with a nicotine patch, varenicline, or combination nicotine replacement therapy (nicotine patch + nicotine lozenge [C-NRT]), in adults trying to quit smoking.